Blog
Research Methodology Insights
Practical guides on causal inference, study design, and statistical methods — written for researchers who care about getting the design right before touching the model.
Differential Misclassification: When One Study Arm Gets More Chances to Be Wrong
A practical guide to differential misclassification for clinical researchers. Covers arm-specific outcome detection, adjudication asymmetry, false positives, missed events, and what reviewers should demand before trusting an effect estimate.
Latest picks
Freshest in the archiveAdaptive Enrichment Trials: When Precision for One Subgroup Pretends to Be Evidence for Everyone
A practical guide to adaptive enrichment trials for clinical researchers. Covers predictive versus prognostic enrichment, assay timing, multiplicity, external validity, and what reviewers should demand before trusting a biomarker-selected win.
Treatment-Induced Mediator-Outcome Confounding: When Mediation Analysis Starts Chasing the Consequences of Treatment
A practical guide to treatment-induced mediator-outcome confounding for clinical researchers. Covers why natural direct and indirect effects fail when treatment changes later severity, toxicity, adherence, or surveillance that affect both the mediator and outcome.
Surrogate Endpoints: When a Biomarker Improvement Pretends to Be Patient Benefit
A practical guide to surrogate endpoints for clinical researchers. Covers validated versus merely plausible surrogates, classic failure modes, and what reviewers should demand before trusting a biomarker-driven trial claim.
Browse all guides
Filter by method family or search for the exact problem you're trying to solve.
Data Leakage in Clinical Prediction Models: When the Model Learns the Future
A practical guide to data leakage in clinical prediction models for clinical researchers. Covers post-outcome features, workflow proxies, validation traps, and what reviewers should demand before trusting a headline AUC.
Net Reclassification Improvement: When a New Biomarker Wins by Moving Patients Between the Wrong Boxes
A practical guide to net reclassification improvement for clinical researchers. Covers event and non-event NRI, arbitrary risk categories, overtreatment traps, and what reviewers should demand before trusting claims that a new model improved classification.
AI-Assisted Methods Review: What LLMs Can Catch, What They Cannot, and Where Judgment Still Matters
A practical guide to AI-assisted methods review for clinical researchers. Covers where LLMs help with structural critique, where source verification and causal judgment still require humans, and what reviewers should demand before trusting AI-generated methodological comments.
Decision Curve Analysis: When a Better AUC Still Makes Worse Clinical Decisions
A practical guide to decision curve analysis for clinical researchers. Covers net benefit, threshold probability, when prediction models fail to beat treat-all or treat-none strategies, and what reviewers should demand before trusting claims of clinical utility.
Channeling Bias: When the Newer Treatment Inherits the Easier Patients
A practical guide to channeling bias for clinical researchers. Covers preferential prescribing, formulary-era drift, specialist selection, and what reviewers should demand before trusting observational comparisons of newer therapies.
When Death Changes the Question: Competing Risks, Intercurrent Events, and Truncation by Death
A practical guide to the boundary between competing risks, intercurrent events, and truncation by death for clinical researchers. Covers when death changes risk sets, when it makes later outcomes undefined, and what reviewers should demand instead of vague censoring language.
Jump-to-Reference Imputation: When Missing Outcomes Start Borrowing the Control Arm's Future
A practical guide to jump-to-reference imputation for clinical researchers. Covers what J2R assumes after treatment discontinuation, when it helps sensitivity analysis, and when it quietly answers the wrong estimand.
Multiple Testing in Clinical Trials: When One Positive Endpoint Is Just the Loudest Coin Flip
A practical guide to multiple testing in clinical trials for clinical researchers. Covers endpoint families, subgroup fishing, interim looks, alpha control, and what reviewers should demand before trusting a lone positive result.
Confounding by Contraindication: When the Untreated Group Is Too Fragile for the Therapy
A practical guide to confounding by contraindication for clinical researchers. Covers how treatment avoidance in high-risk patients can make therapies look safer or more effective than they are, and what reviewers should demand instead.
Last Observation Carried Forward: When Yesterday's Outcome Pretends the Patient Stopped Changing
A practical guide to last observation carried forward for clinical researchers. Covers why LOCF fails as missing-data strategy, how it can exaggerate or dilute treatment effects, and what reviewers should demand instead.
Time Zero Alignment: When Your Cohort Starts Counting Before Treatment Does
A practical guide to time zero alignment for clinical researchers. Covers eligibility, treatment assignment, delayed initiation, immortal time, and what reviewers should demand before trusting a real-world effect estimate.
Early Stopping for Benefit: When a Trial Quits While the Effect Is Still on Its Best Behavior
A practical guide to early stopping for benefit in clinical trials. Covers interim looks, alpha spending, exaggerated effect sizes, immature follow-up, and what reviewers should demand before trusting a triumphant stop.
Informative Visit Processes: When Who Shows Up Starts Writing the Results
A practical guide to informative visit processes for clinical researchers. Covers endogenous follow-up, unequal observation schedules, visit-triggered outcome capture, inverse-intensity thinking, and what reviewers should demand before trusting longitudinal real-world results.
External Control Arms: When a Comparison Group Arrives from Another Universe
A practical guide to external control arms for clinical researchers. Covers historical and real-world comparators, design drift, prognostic imbalance, endpoint mismatch, and what reviewers should demand before trusting single-arm success stories.
Stochastic Interventions: When “Treat Everyone” Is Not the Policy Question
A practical guide to stochastic interventions for clinical researchers. Covers when deterministic treatment rules become unrealistic, how probability-shift interventions preserve positivity, and what reviewers should demand before trusting policy-effect claims.
Missing Indicator Method: When an NA Flag Pretends to Be Missing-Data Strategy
A practical guide to the missing-indicator method for clinical researchers. Covers why NA flags fail for confounding control, when they leave residual bias, and what reviewers should demand before trusting a covariate-adjusted result.
Regression to the Mean: When Extreme Patients Improve Before Your Treatment Deserves Credit
A practical guide to regression to the mean for clinical researchers. Covers extreme-baseline selection, before-after mirages, symptom flares, biomarker spikes, and what reviewers should demand before trusting dramatic improvement.
Treatment Switching in Oncology Trials: When Overall Survival Becomes a Rescue Protocol Audit
A practical guide to treatment switching in oncology trials for clinical researchers. Covers crossover, overall survival dilution, ITT versus hypothetical estimands, RPSFTM, IPCW, two-stage estimation, and what reviewers should demand before trusting an adjusted survival claim.
Run-In Periods: When Your Trial Randomizes the Easy Patients First
A practical guide to run-in periods for clinical researchers. Covers adherence enrichment, tolerability selection, estimand drift, external validity, and what reviewers should demand before trusting a polished randomized cohort.
Washout Periods: When “New Use” Is Just Old Use with Better PR
A practical guide to washout periods for clinical researchers. Covers new-user definitions, refill cycles, intermittent treatment, data-history limits, and what reviewers should demand before trusting an incident-user cohort.
Exposure Lagging: When Your Induction Window Becomes Wishful Thinking
A practical guide to exposure lagging for clinical researchers. Covers induction periods, reverse causation, protopathic bias, estimand drift, and what reviewers should demand before trusting a lagged analysis.
Responder Analyses: When a Cutoff Turns a Clinical Gradient into a Headline
A practical guide to responder analyses for clinical researchers. Covers dichotomizing continuous outcomes, post hoc thresholds, baseline dependence, power loss, and what reviewers should demand before trusting "X% achieved response" claims.
Healthy Adherer Bias: When Persistence Looks Like Pharmacology
A practical guide to healthy adherer bias for clinical researchers. Covers why adherent patients often look healthier before the treatment effect is even estimated, how this differs from confounding by indication, and what reviewers should demand before trusting adherence-based benefit claims.
Grace Periods in Target Trial Emulation: Clinical Realism or Future Information in Disguise?
A practical guide to grace periods in target trial emulation for clinical researchers. Covers when a grace window is defensible, when it becomes immortal time in formalwear, and what reviewers should demand before trusting the result.
Index Event Bias: When Your Cohort Already Selected the Wrong Comparison
A practical guide to index event bias for clinical researchers. Covers recurrence-risk paradoxes, conditioning on the first event, secondary prevention cohorts, and what reviewers should demand before trusting protective-looking associations inside diseased cohorts.
Calendar Time Confounding: When Secular Trends Pretend Your Intervention Worked
A practical guide to calendar time confounding for clinical researchers. Covers secular trends, treatment diffusion, concurrent comparators, and what reviewers should demand before trusting real-world benefit that may just reflect a later era.
Surveillance Bias: When One Group Gets More Chances to Become a Case
A practical guide to surveillance bias for clinical researchers. Covers differential testing, follow-up intensity, diagnosis-based outcomes, and what reviewers should demand before trusting higher event rates.
Outcome Switching: When the Primary Endpoint Moves After the Results Get Interesting
A practical guide to outcome switching for clinical researchers. Covers endpoint shopping, selective reporting, protocol drift, and what reviewers should demand before trusting a late-breaking primary outcome.
Overdiagnosis: When Finding More Disease Does Not Mean Saving More Lives
A practical guide to overdiagnosis for clinical researchers. Covers how screening can raise incidence and improve survival statistics without reducing mortality, how to separate lead-time from true overdiagnosis, and what reviewers should demand before trusting the headline.
Prevalent-User Bias: When Your Drug Study Starts After the Interesting Harm Already Happened
A practical guide to prevalent-user bias for clinical researchers. Covers depletion of susceptibles, survivor selection, post-treatment baseline covariates, and what reviewers should demand before trusting late-entry treatment cohorts.
Lead-Time Bias: When Earlier Diagnosis Pretends to Be Better Survival
A practical guide to lead-time bias for clinical researchers. Covers why screening can improve survival statistics without reducing mortality, how to separate earlier detection from real benefit, and what reviewers should demand before trusting the headline.
Clone-Censor-Weight: The Target Trial Fix That Still Breaks When You Use It Casually
A practical guide to clone-censor-weight for clinical researchers. Covers when the design is needed, how cloning and artificial censoring work, where immortal time bias reappears, and what reviewers should demand before trusting a target trial emulation.
MNAR Sensitivity Analysis: Because “We Assumed MAR” Is Not a Results Section
A practical guide to MNAR sensitivity analysis for clinical researchers. Covers when multiple imputation under MAR is not enough, how to think about missing not at random assumptions, and what reviewers should demand before trusting complete-case comfort.
Subgroup Analysis: When “Personalized” Findings Are Mostly Multiplicity Wearing a Stethoscope
A practical guide to subgroup analysis for clinical researchers. Covers interaction testing, multiplicity, power failure, post hoc storytelling, and what reviewers should demand before trusting treatment-effect heterogeneity claims.
Noncollapsibility of Odds Ratios: Why Adjustment Can Change the Number Even When Confounding Did Not
A practical guide to noncollapsibility of odds ratios for clinical researchers. Covers why crude and adjusted odds ratios can differ without confounding, when logistic regression invites over-interpretation, and what reviewers should demand instead.
Composite Endpoints: When One Trial Outcome Quietly Becomes Four Different Clinical Questions
A practical guide to composite endpoints for clinical researchers. Covers when endpoint bundles improve efficiency, when they distort clinical meaning, how soft components hijack results, and what reviewers should demand before trusting the headline.
Per-Protocol Effects: The Estimand Everyone Wants and the Bias Trap They Usually Build
A practical guide to per-protocol effects for clinical researchers. Covers sustained-adherence estimands, naive as-treated failure, selection bias after protocol deviation, and what reviewers should demand before trusting per-protocol claims.
Prediction vs Causation: Why Your Best Risk Model Still Cannot Tell You What to Treat
A practical guide for clinical researchers on the difference between prediction and causation. Covers why strong risk models do not identify treatment effects, how to frame the right estimand, and what reviewers should flag in AI-driven clinical studies.
Restricted Mean Survival Time: When Hazard Ratios Are Not the Clinical Answer
A practical guide to restricted mean survival time for clinical researchers. Covers what RMST estimates, when it beats the hazard ratio, how to choose the time horizon, and how to report results clinicians can actually interpret.
Landmark Analysis: Useful, Honest, and Frequently Overclaimed
A practical guide to landmark analysis for clinical researchers. Covers delayed treatment, immortal time bias, conditional survivor populations, landmark selection, and why a cleaner timeline still changes the causal question.
Targeted Maximum Likelihood Estimation: Doubly Robust, Not Doubly Forgiving
A practical guide to targeted maximum likelihood estimation for clinical researchers. Covers nuisance models, clever covariates, machine learning, overlap diagnostics, and why TMLE is robust in theory but never permission to stop thinking.
Case-Crossover Design: When Patients Become Their Own Controls
A practical guide to case-crossover designs for clinical researchers. Covers self-matching, hazard versus control windows, transient exposures, protopathic bias, time trends, and when this elegant design is exactly right or exactly wrong.
Multiple Imputation: Missing Data Does Not Become Innocent Because MICE Ran
A practical guide to multiple imputation for clinical researchers. Covers MICE, complete-case failure, MAR versus MNAR, imputation-model design, and why missing data needs causal thinking instead of software ritual.
G-Computation: Predict the Outcome Under Each Treatment Strategy
A practical guide to g-computation for clinical researchers. Covers counterfactual prediction, standardization, outcome modeling, positivity, model misspecification, and how to estimate causal effects by averaging predicted outcomes under competing interventions.
Estimands: The Causal Question You Should Define Before Running the Analysis
A practical guide to estimands for clinical researchers. Covers treatment strategies, intercurrent events, target populations, summary measures, and why many studies fail because they never define the actual causal question clearly.
Time-Varying Confounding: When Yesterday's Treatment Changes Today's Confounder
A practical guide to time-varying confounding for clinical researchers. Covers treatment-confounder feedback, why ordinary regression fails, and how MSMs, g-methods, and target trial logic handle evolving treatment decisions.
Informative Censoring: When Dropout Is Part of the Bias
A practical guide to informative censoring for clinical researchers. Covers loss to follow-up, treatment discontinuation, database exit, inverse probability of censoring weights, and why dropout can bias survival and causal estimates when it depends on prognosis.
Self-Controlled Case Series: When Each Patient Becomes Their Own Control
A practical guide to self-controlled case series for clinical researchers. Covers transient exposures, acute outcomes, fixed-confounding control, event-dependent exposure, and why within-person designs still live or die on timing assumptions.
Measurement Error: When Bad Variables Break Good Causal Methods
A practical guide to measurement error for clinical researchers. Covers noisy exposures, weak confounder proxies, surveillance-driven outcomes, validation strategies, and why sophisticated causal methods cannot rescue bad variables.
Competing Risks: When Kaplan-Meier Tells the Wrong Clinical Story
A practical guide to competing risks for clinical researchers. Covers death and discharge as competing events, why Kaplan-Meier can overstate event probability, and how cause-specific hazards and cumulative incidence answer different clinical questions.
Bias Amplification: When Adjustment Makes Unmeasured Confounding Worse
A practical guide to bias amplification for clinical researchers. Covers near-instruments, noisy severity proxies, treatment-prediction traps, and why the wrong adjustment variable can magnify residual confounding instead of reducing it.
Misclassification Bias: When Your Variables Lie Before the Model Starts
A practical guide to misclassification bias for clinical researchers. Covers wrong exposure and outcome labels, weakly measured confounders, surveillance-driven event detection, and why bad variables can distort causal estimates before modeling even begins.
Active Comparator New-User Design: The Observational Study Upgrade Most Drug Papers Need
A practical guide to the active comparator new-user design for clinical researchers. Covers why treated-versus-untreated comparisons fail, how new-user cohorts reduce prevalent-user bias, how active comparators narrow confounding by indication, and what reviewers should demand before trusting comparative effectiveness claims.
Selection Bias: When Your Study Sample Is the Problem
A practical guide to selection bias for clinical researchers. Covers referral filtering, survivor bias, complete-case analysis, informative loss to follow-up, collider-driven selection, and why a clean model cannot rescue a distorted sample.
Confounding by Indication: When Sicker Patients Make Treatments Look Dangerous
A practical guide to confounding by indication for clinical researchers. Covers treatment selection, severity-driven prescribing, contraindication bias, why routine adjustment often fails, and how to design observational comparisons that do not confuse prognosis with treatment effect.
Immortal Time Bias: The Fake Survival Advantage Hiding in Bad Study Design
A practical guide to immortal time bias for clinical researchers. Covers time zero, future-based exposure definitions, delayed treatment initiation, target trial emulation, and why you cannot adjust your way out of a broken timeline.
Interrupted Time Series: Strong Quasi-Experiments Need More Than a Before-and-After Plot
A practical guide to interrupted time series for clinical researchers. Covers level and slope changes, segmented regression, seasonality, autocorrelation, controlled ITS designs, and why a vertical line on a chart is not a causal estimate.
Parametric G-Formula: Estimating Causal Effects When Covariates Change Over Time
A practical guide to the parametric g-formula for clinical researchers. Covers time-varying confounding, dynamic treatment strategies, longitudinal simulation, model diagnostics, and why ordinary regression breaks when covariates are changed by prior treatment.
Proximal Causal Inference: What to Do When Unmeasured Confounding Is Still on the Table
A practical guide to proximal causal inference for clinical researchers. Covers proxy variables, treatment-inducing versus outcome-inducing proxies, bridge functions, completeness, and why this method is powerful but brutally assumption-heavy.
Positivity & Overlap: The Assumption Your Causal Estimate Cannot Survive Without
A practical guide to positivity and overlap for clinical researchers. Covers common support, extreme weights, trimming, overlap-focused estimands, and why many causal analyses fail because treated and untreated patients barely resemble each other.
Transportability & External Validity: When Your Causal Estimate Travels, and When It Absolutely Does Not
A practical guide to transportability and external validity for clinical researchers. Covers target populations, effect heterogeneity, trial selection, overlap, reweighting, and why “generalizable” is usually a lazy claim unless you prove the estimate can actually travel.
Collider Bias: How Adjustment Can Manufacture Associations
A practical guide to collider bias for clinical researchers. Covers common-effect conditioning, Berkson bias, selected cohorts, complete-case traps, and why the wrong adjustment set can literally manufacture a result.
Interference & Spillover Effects: When One Patient's Treatment Changes Another's Outcome
A practical guide to interference and spillover effects for clinical researchers. Covers SUTVA violations, direct versus indirect effects, partial interference, cluster and network designs, and why contamination is often the estimand trying to get your attention.
Principal Stratification: Estimating Effects When Post-Treatment Variables Matter
A practical guide to principal stratification for clinical researchers. Covers compliers, always-takers, truncation by death, latent strata, CACE/LATE, and why conditioning on observed post-treatment subgroups is usually causal self-sabotage.
Overadjustment Bias: When More Covariates Make Causal Inference Worse
A practical guide to overadjustment bias for clinical researchers. Covers mediators, colliders, post-treatment variables, propensity score misuse, and why the biggest adjustment set is often the least credible one.
Front-Door Criterion: The Causal Backdoor Alternative Nobody Uses Enough
A practical guide to the front-door criterion for causal inference. Covers full mediation, mediator-outcome confounding, identification logic, DAG requirements, and why most real datasets are nowhere near clean enough for a credible front-door design.
Negative Controls: The Bias Check Most Observational Studies Skip
A practical guide to negative control outcomes and exposures for clinical researchers. Covers residual confounding, selection bias, surveillance bias, falsification endpoints, and how to interpret a failed negative control without lying to yourself.
DAG Construction: How to Draw a Causal Graph Before You Touch the Model
A practical guide to DAG construction for clinical researchers. Covers time ordering, node selection, confounders vs mediators vs colliders, minimally sufficient adjustment sets, and why most covariate lists are just causal confusion wearing a regression badge.
Mediation Analysis: When You Want the Mechanism, Not Just the Effect
A practical guide to mediation analysis for clinical researchers. Covers direct and indirect effects, mediator-outcome confounding, treatment-induced confounding, interventional effects, and why most mediator-adjusted regressions are wrong.
G-Estimation: The Causal Method You Reach For When Time-Varying Confounding Breaks Regression
A practical guide to g-estimation and structural nested models for clinical researchers. Covers treatment-confounder feedback, blipped-down outcomes, identifying assumptions, and when g-estimation beats naive longitudinal regression or unstable weights.
Causal Forests: Finding Treatment Effect Heterogeneity Without Fooling Yourself
A practical guide to causal forests for estimating who benefits more, less, or not at all. Covers CATEs, honest splitting, overlap, validation, clinical use cases, and the reporting standards reviewers should expect.
E-values & Sensitivity Analysis: How to Stress-Test Causal Claims
A practical guide to the one question every observational study must answer: how strong would an unmeasured confounder have to be to erase your result? Covers E-values, confidence-limit interpretation, Rosenbaum bounds, negative controls, and the reporting language reviewers trust.
Mendelian Randomization: Using Genetics as Nature's Randomized Trial
How genetic variants serve as natural instruments for causal inference — and why horizontal pleiotropy, population stratification, and weak instruments break most published MR studies. Covers two-sample MR, MR-Egger, MR-PRESSO, and the STROBE-MR reporting checklist.
Marginal Structural Models: A Practical Guide for Clinical Researchers
How MSMs use stabilized inverse probability weights to handle time-varying confounders — the ones that change over time and are affected by prior treatment. Covers weight estimation, model fitting, clinical examples, and common pitfalls.
Structural Causal Models & DAGs: A Practical Guide for Clinical Researchers
The causal framework behind every method you use. Covers DAGs, d-separation, do-calculus, backdoor/frontdoor criteria, mediation analysis, and how to draw the graph that makes your analysis work.
Inverse Probability Weighting: When PSM Discards Your Data
Why IPW outperforms matching by keeping all patients — and how extreme weights, positivity violations, and wrong variance estimators break published analyses silently.
Double Machine Learning: A Practical Guide for Clinical Researchers
How DML uses machine learning to estimate causal effects while controlling for high-dimensional confounders. Covers cross-fitting, Neyman orthogonality, clinical applications, and implementation in EconML.
Target Trial Emulation: A Practical Guide for Clinical Researchers
The framework that bridges observational data and causal claims — by asking what RCT you wish you had. Covers protocol specification, time zero alignment, clone-censor-weight, immortal time bias, and reporting.
Regression Discontinuity Design: A Practical Guide for Clinical Researchers
RDD turns arbitrary thresholds into causal evidence. Covers sharp vs fuzzy designs, bandwidth selection, manipulation testing, clinical applications, and a complete reporting checklist.
Synthetic Control Methods: Building Counterfactuals When DID Fails
How to construct a synthetic twin from donor pools when parallel trends don't hold. Covers SCM optimization, validation via placebo tests, modern extensions (ASCM, SDID), and common pitfalls.
Difference-in-Differences: A Practical Guide for Clinical Researchers
When and how to use DID in clinical research. Covers parallel trends, staggered adoption, common pitfalls, reporting checklist, and modern estimators.
Instrumental Variables: When Observational Data Meets Unmeasured Confounding
When PSM and regression fail because of unmeasured confounding, IV methods offer a way forward. A practical guide covering instruments, LATE, Mendelian randomization, and the exclusion restriction.
Propensity Score Matching: A Practical Guide for Clinical Researchers
What PSM actually does, when it fails, and how to report it correctly. Written for researchers who want to use it — not just cite it.